Reproductive Health (Jul 2022)

Aspectos clínicos y epidemiológicos de la infección por SARS-CoV-2 en mujeres embarazadas y puérperas en Mozambique: un estudio de cohorte prospectivo

  • Charles M’poca Charles,
  • Nafissa Bique Osman,
  • Domingos Arijama,
  • Benjamim Matingane,
  • Tomás Sitoé,
  • Darlene Kenga,
  • Cesaltina Lorenzoni,
  • Elvira Luís,
  • Rodolfo de Carvalho Pacagnella,
  • Jahit Sacarlal,
  • for the Mozambique Study group of SARS-COV-2

DOI
https://doi.org/10.1186/s12978-022-01469-9
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 11

Abstract

Read online

Plain language summary The epidemiological pattern of the COVID-19 pandemic in Africa is heterogeneous, and many African countries are still struggling to establish efficient testing policy, guarantee sufficient laboratory supply and achieve or maintain adequate testing capacity. In addition, evidence suggests that sexual and reproductive health services were the most affected by the pandemic; this scenario might have devastating effects on maternal and perinatal health. Moreover, data from non-sub-Saharan countries the SARS-CoV-2 infection among pregnant and postpartum women is associated with an increased risk of adverse maternal and neonatal health (preterm birth, preeclampsia and maternal death). Although there is a significant increase of evidence regarding the prevalence and impact of COVID-19 on maternal and perinatal health, data on the effects of this condition on the obstetric population in low-income countries are scarce. Therefore, the study objective were to assess the prevalence and impact of COVID-19 on maternal and neonatal health at referral maternity in Maputo, Mozambique. Our findings suggest that the prevalence of COVID-19 in the obstetric population is higher than the general population, and most pregnant and postpartum women are asymptomatic. Being pregnant, not having a partner and alcohol consumption were factors of greatest vulnerability to SARS-COV-2 infection. Moreover, the risk of COVID-19 among pregnant was seven-fold higher than in postpartum women. Pregnant women with COVID-19 may have a higher frequency of adverse gestational outcomes (foetal death and abortion). Although the risk of adverse maternal outcomes (death, Severe Acute Respiratory Syndrome and Intensive Care Unit admission) did not differ significantly between the COVID-19 and COVID-19 negative groups, universal screening for COVID-19 should be implemented to ensure adequate management of pregnant women and newborns.

Keywords